FABRAZYME
Live / Registered — Registered and renewed (as of 29 Apr 2022)
What this means for you
Registered since 08 Jan 2002. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 08 Jan 2022).
Record
- Serial number
- 75844246
- Registration number
- 2528286
- Mark type
- Word mark
- Filed
- 10 Nov 1999
- Published for opposition
- 15 Aug 2000
- Registered
- 08 Jan 2002
- Next maintenance due
- 08 Jan 2022
- Attorney of record
- Karen Lim
Goods and services
- Class 005 — Pharmaceuticals: PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF FABRY DISEASE
Owner
- GENZYME CORPORATION, CAMBRIDGE, MA, US
- GENZYME THERAPEUTIC PRODUCTS LIMITED PAR, CAMBRIDGE, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
- Genzyme Corporation, Cambridge, MA, US
Prosecution history
- 29 Jan 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 29 Apr 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 29 Apr 2022 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 29 Apr 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 29 Apr 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Jan 2022 — TEAS SECTION 8 & 9 RECEIVED
- 08 Jan 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Sept 2011 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Sept 2011 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Sept 2011 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Aug 2011 — TEAS SECTION 8 & 9 RECEIVED
- 16 Apr 2007 — CASE FILE IN TICRS
- 12 Apr 2007 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 28 Mar 2007 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 01 Mar 2007 — ASSIGNED TO PARALEGAL